Captisol
Manufacturing · France · 201-500 Employees
View Company Info for Free
Overview
Headquarters
8 Place De La Liberation, Herblay, Ile-d...Phone Number
(858) 550-7500Website
www.captisol.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Captisol
Captisol, produced by CyDex Pharmaceuticals, is a leading pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD) utilized in 16 FDA-approved products, including VEKLURY and KYPROLIS, to enhance the solubility and stability of challenging molecules. The technology is applicable across various therapeutic routes, such as parenteral, oral, and inhalation, and is increasingly being explored for consumer health and personal care products. Captisol offers comprehensive drug development services, including formulation development and regulatory affairs consultation, catering to clients at all stages of drug development. The company also provides opportunities for licensing and partnerships to facilitate the testing and integration of Captisol in new product candidates.Explore more
Captisol Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Captisol your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Captisol, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Captisol recently announced quarterly report
Click to see if Captisol had a recent Job posting/layoffs
Product Launch: Get notified when Captisol launches new products
Congratulate Masked Content for being promoted to Masked Content at Captisol
Funding: Get notified immidiatlly once Captisol has new funding data
Check out if Captisol is spiking on competitors!
Check if Captisol has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Captisol as Masked Content
Find 2 more new buyers
Compare Similar Companies to Captisol
Compare insights from companies similar to Captisol, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Captisol is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Captisol is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Captisol.
Captisol Tech Stack
A closer look at the technologies used by Captisol
See more technologies
Captisol News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Captisol
Sign Up For FreeTo access detailed company insights
Captisol, produced by CyDex Pharmaceuticals, is a leading pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD) utilized in 16 FDA-approved products, including VEKLURY and KYPROLIS, to enhance the solubility and stability of challenging molecules. The technology is applicable across various therapeutic routes, such as parenteral, oral, and... Read More
